Dr. Jonathan Gutman, MD
Claim this profileUniversity of Colorado Hospital
Area of expertise
Mixed-Cell Lymphoma
Jonathan Gutman, MD has run 2 trials for Mixed-Cell Lymphoma.
Cancer
Jonathan Gutman, MD has run 2 trials for Cancer. Some of their research focus areas include:
Affiliated Hospitals
University Of Colorado Hospital
University Of Colorado School Of Medicine. Anschutz Medical Campus
Clinical Trials Jonathan Gutman, MD is currently running
Shingrix Vaccine
for Bone Marrow Transplant Recipients
This research is designed to determine if the adjuvanted recombinant glycoprotein E (gE) herpes zoster (HZ) vaccine (Shingrix) has acceptable immunogenicity and safety in people who have undergone allogeneic stem cell transplant (allo-SCT). Specifically, it will determine the effect of the interval after transplantation on the immune response and if an additional dose of vaccine is needed to improve the vaccine-induced responses.
Recruiting
1 award
Phase 2
9 criteria
CAR T Cell Therapy
for Non-Hodgkin's Lymphoma
This open-label, single arm phase 1 trial aims to determine the safety and tolerability of anti-CD19 and anti-CD22 chimeric antigen receptor-expressing (CAR) T cells (CD19x22 CAR T) in adolescents and adults with relapsed/refractory (R/R) B-cell Non-Hodgkin Lymphoma (B-NHL). This trial will determine the maximum tolerated dose of CD19x22 CAR T cells using a standard 3+3 trial design.
Recruiting
1 award
Phase 1
More about Jonathan Gutman, MD
Clinical Trial Related
2 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 5 Active Clinical Trials
Treatments Jonathan Gutman, MD has experience with
- Haploidentical CD34+ Selected Cells Combined With Single Unit Umbilical Cord Blood Transplant
- Miltenyi CliniMACS® CD34 Reagent System
- CD19x22 CAR T Cells
- ECT-001-CB (UM171-Expanded Cord Blood Transplant)
- Unlicensed CBU
- Unlicensed Cryopreserved Cord Blood Units
Breakdown of trials Jonathan Gutman, MD has run
Childhood Blood Disease
Blood Disorders
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jonathan Gutman, MD specialize in?
Jonathan Gutman, MD focuses on Mixed-Cell Lymphoma and Cancer. In particular, much of their work with Mixed-Cell Lymphoma has involved treating patients, or patients who are undergoing treatment.
Is Jonathan Gutman, MD currently recruiting for clinical trials?
Yes, Jonathan Gutman, MD is currently recruiting for 5 clinical trials in Aurora Colorado. If you're interested in participating, you should apply.
Are there any treatments that Jonathan Gutman, MD has studied deeply?
Yes, Jonathan Gutman, MD has studied treatments such as Haploidentical CD34+ Selected Cells Combined With Single Unit Umbilical Cord Blood Transplant, Miltenyi CliniMACS® CD34 Reagent System, CD19x22 CAR T Cells.
What is the best way to schedule an appointment with Jonathan Gutman, MD?
Apply for one of the trials that Jonathan Gutman, MD is conducting.
What is the office address of Jonathan Gutman, MD?
The office of Jonathan Gutman, MD is located at: University of Colorado Hospital, Aurora, Colorado 80045 United States. This is the address for their practice at the University of Colorado Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.